Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 248 Records) |
| Query Trace: Fibrosis and PNPLA3[original query] |
|---|
| Impact of PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease progression. Hepatology (Baltimore, Md.) 2023 8 . Ines Volkert, Malin Fromme, Carolin Schneider, Lena Candels, Cecilia Lindhauer, Huan Su, Katrine Thorhauge, Monica Pons, Mohamed Ramadan Mohamed, Kai Markus Schneider, Pavel Strnad, Christian Trautwe |
| Influence of the Bile Acid Transporter Genes ABCB4, ABCB8, and ABCB11 and the Farnesoid X Receptor on the Response to Ursodeoxycholic Acid in Patients with Nonalcoholic Steatohepatitis. Journal of personalized medicine 2023 7 13 (7): . Henriette Kreimeyer, Katharina Vogt, Tobias Götze, Jan Best, Oliver Götze, Jochen Weigt, Alisan Kahraman, Mustafa Özçürümez, Julia Kälsch, Wing-Kin Syn, Svenja Sydor, Ali Canbay, Paul Man |
| Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2023 7 . Rosa Lombardi, Lucia Colavolpe, Francesca Alletto, Annalisa Cespiati, Erika Fatta, Cristina Bertelli, Felice Cinque, Giuseppina Pisano, Edoardo Pulixi, Paolo Francione, Gabriele Maffi, Federica Iuculano, Paola Dongiovanni, Larry Burdick, Daniela Bignamini, Marco Maggioni, Luca Valenti, Silvia Fargion, Anna Ludovica Fracanza |
| Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality. JAMA network open 2023 6 6 (6): e2320222. Mara Sophie Vell, Rohit Loomba, Arunkumar Krishnan, Kirk J Wangensteen, Jonel Trebicka, Kate Townsend Creasy, Christian Trautwein, Eleonora Scorletti, Katharina Sophie Seeling, Leonida Hehl, Miriam Daphne Rendel, Inuk Zandvakili, Tang Li, Jinbo Chen, Marijana Vujkovic, Saleh Alqahtani, Daniel James Rader, Kai Markus Schneider, Carolin Victoria Schneid |
| Age, BMI, and type2 diabetes modify the relationship between PNPLA3 and advanced fibrosis in children and adults with NAFLD. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2023 12 . Chaowapong Jarasvaraparn, Eduardo Vilar-Gomez, Katherine P Yates, Laura A Wilson, Brent Neuschwander-Tetri, Rohit Loomba, Oscar Cummings, Miriam Vos, Stavra Xanthakos, Jeffrey Schwimmer, Jean P Molleston, Arun Sanyal, James Tonascia, Naga Chalasa |
| Parental History of Type 2 Diabetes Mellitus and PNPLA3 Polymorphism Increase the Risk of Severe Stages of Nonalcoholic Fatty Liver Disease. Digestive diseases and sciences 2023 12 . Natalia Balassiano Wajsbrot, Nathalie Carvalho Leite, Paulo Henrique Condeixa Franca, Claudia Regina Lopes Cardoso, Gil Fernando Salles, Cristiane A Villela-Noguei |
| Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype. Cancer science 2023 12 . Jennifer Tai, Chao-Wei Hsu, Wei-Ting Chen, Sien-Sing Yang, Cheng-Hsun Chiu, Rong-Nan Chien, Ming-Ling Cha |
| Associations between metabolic hyperferritinaemia, fibrosis-promoting alleles and clinical outcomes in steatotic liver disease. Liver international : official journal of the International Association for the Study of the Liver 2023 11 . Deepika Suresh, Ashley Li, Matthew J Miller, Karn Wijarnpreecha, Vincent L Ch |
| PNPLA3 rs738409 Genetic Variant Inversely Correlates with Platelet Count, Thereby Affecting the Performance of Noninvasive Scores of Hepatic Fibrosis. International journal of molecular sciences 2023 10 24 (20): . Marica Meroni, Paola Dongiovan |
| SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease. Journal of hepatology 2023 10 . Federico Salomone, Rosaria Maria Pipitone, Francesco Malvestiti, Miriam Longo, Angela Maria Amorini, Alfio Distefano, Elia Casirati, Ester Ciociola, Nunzio Iraci, Loredana Leggio, Rossella Zito, Nunzio Vicario, Concetta Saoca, Grazia Pennisi, Daniela Cabibi, Giuseppe Lazzarino, Anna Ludovica Fracanzani, Paola Dongiovanni, Luca Valenti, Salvatore Petta, Giovanni Li Volti, Stefania Grimau |
| PNPLA3 I148 M genetic variant in autoimmune hepatitis characterises advanced disease at diagnosis and reduced survival free of cirrhotic events and liver-related mortality. Journal of translational autoimmunity 2024 7 9 100243. Kalliopi Azariadis, Nikolaos K Gatselis, Aggeliki Lyberopoulou, Pinelopi Arvaniti, Kalliopi Zachou, Stella Gabeta, George N Dalek |
| Insulin resistance is an integral feature of MASLD even in the presence of PNPLA3 variants. JHEP reports : innovation in hepatology 2024 7 6 (7): 101092. Fernando Bril, Srilaxmi Kalavalapalli, Romina Lomonaco, Reginald Frye, Eddison Godinez Leiva, Kenneth Cu |
| The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes. Alimentary pharmacology & therapeutics 2024 6 . Lana Bridi, Saaket Agrawal, Kaleb Tesfai, Egbert Madamba, Ricki Bettencourt, Lisa M Richards, Amit V Khera, Rohit Loomba, Veeral Ajme |
| Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population. Clinics and research in hepatology and gastroenterology 2024 6 48 (7): 102389. Elias Badal Rashu, Mikkel Parsberg Werge, Liv Eline Hetland, Mira Thing, Puria Nabilou, Nina Kimer, Anders Ellekaer Junker, Anne-Sofie Houlberg Jensen, Børge Grønne Nordestgaard, Stefan Stender, Lise Lotte Glu |
| Distinct Gut Microbial Signature and Host Genetic Variants in Association with Liver Fibrosis Severity in Patients with MASLD. Nutrients 2024 6 16 (12): . Nantawat Satthawiwat, Thananya Jinato, Sawannee Sutheeworapong, Natthaporn Tanpowpong, Natthaya Chuaypen, Pisit Tangkijvani |
| Are transmembrane 6 superfamily member 2 gene polymorphisms associated with steatohepatitis after pancreaticoduodenectomy? JGH open : an open access journal of gastroenterology and hepatology 2024 6 8 (6): e13113. Tomotaka Mori, Eisuke Ozawa, Ryu Sasaki, Akane Shimakura, Kosuke Takahashi, Yoko Kido, Yasuko Kanda, Satoshi Matsuo, Kazuaki Tajima, Asami Beppu, Yasuhiko Nakao, Masanori Fukushima, Masafumi Haraguchi, Satoshi Miuma, Hisamitsu Miyaaki, Tomohiko Adachi, Susumu Eguchi, Shinji Okano, Kazuhiko Nak |
| Fibroblast growth factor 21 is a hepatokine involved in MASLD progression. United European gastroenterology journal 2024 6 . Rocío Gallego-Durán, Javier Ampuero, Douglas Maya-Miles, Helena Pastor-Ramírez, Rocío Montero-Vallejo, Jesús Rivera-Esteban, Leticia Álvarez-Amor, María Jesús Pareja, María Carmen Rico, Raquel Millán, María José Robles-Frías, Rocío Aller, Ángela Rojas, Rocío Muñoz-Hernández, Antonio Gil-Gómez, Sheila Gato, María García-Lozano, María Teresa Arias-Loste, Javier Abad, José Luis Calleja, Raúl J Andrade, Javier Crespo, Águeda González-Rodríguez, Carmelo García-Monzón, Fausto Andreola, Juan Manuel Pericás, Rajiv Jalan, Francisco Martín-Bermudo, Manuel Romero-Góm |
| Liver fibrosis assessed via non-invasive tests is associated with incident heart failure in a general population cohort. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024 5 . Theresa J Hydes, Oliver J Kennedy, Kate Glyn-Owen, Ryan Buchanan, Julie Parkes, Daniel J Cuthbertson, Paul Roderick, Christopher D Byr |
| Integrating genetic and socioeconomic data to predict the progression of nonalcoholic fatty liver disease. American journal of biological anthropology 2024 5 e24979. Maria C Rieman-Klingler, Jinho Jung, Kaleb Tesfai, Rohit Loomba, Amy L N |
| Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohort. Journal of hepatology 2024 4 . Vincent L Chen, Xiaomeng Du, Antonino Oliveri, Yanhua Chen, Annapurna Kuppa, Brian D Halligan, Michael A Province, Elizabeth K Speliot |
| Relevance of PNPLA3, TM6SF2, HSD17B13, and GCKR Variants to MASLD Severity in an Egyptian Population. Genes 2024 4 15 (4): . Nehal Elmansoury, Ahmed A Megahed, Ahmed Kamal, Nefertiti El-Nikhely, Marina Labane, Manal Abdelmageed, Ann K Daly, Ahmed Wah |
| PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic-associated steatotic liver disease. Hepatology (Baltimore, Md.) 2024 4 . Naga Chalasani, Eduardo Vilar-Gomez, Rohit Loomba, Katherine P Yates, Anna Mae Diehl, Brent A Neuschwander-Tetri, Srinivasan Dasarathy, Kris V Kowdley, Norah Terrault, Laura A Wilson, James Tonascia, Arun Sany |
| Differential effects of genetic polymorphism on comorbid disease in metabolic dysfunction-associated steatotic liver disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024 4 . Yuya Seko, Kanji Yamaguchi, Toshihide Shima, Michihiro Iwaki, Hirokazu Takahashi, Miwa Kawanaka, Saiyu Tanaka, Yasuhide Mitsumoto, Masato Yoneda, Atsushi Nakajima, Takeshi Okanoue, Yoshito It |
| An epidemiological study on the factors including genetic polymorphism influencing ALT >30?U/L and liver fibrosis progression in metabolic dysfunction-associated steatotic liver disease among the general population. JGH open : an open access journal of gastroenterology and hepatology 2024 12 8 (12): e70043. Satoshi Sato, Chikara Iino, Takafumi Sasada, Go Soma, Keisuke Furusawa, Kenta Yoshida, Kaori Sawada, Tatsuya Mikami, Shinsaku Fukuda, Shigeyuki Nakaji, Hirotake Sakura |
| Type 2 diabetes and the minor allele of PNPLA3 consistently identify high-risk metabolic dysfunction associated steatotic liver disease. Diabetes research and clinical practice 2024 12 219 111960. Zobair M Younossi, J Michael Estep, Sean Felix, Brian Lam, Zaid Younossi, Andrei Racila, Maria Stepano |
| Impact of PNPLA3 in Lean Individuals and in Cryptogenic Steatotic Liver Disease. Liver international : official journal of the International Association for the Study of the Liver 2024 11 . Yuya Seko, Huapeng Lin, Vincent Wai-Sun Wong, Takeshi Okano |
| Clinical Utility of Genetic Variants in PNPLA3 and TM6SF2 to Predict Liver-Related Events in Metabolic Dysfunction-Associated Steatotic Liver Disease. Liver international : official journal of the International Association for the Study of the Liver 2024 10 . Yuya Seko, Kanji Yamaguchi, Toshihide Shima, Michihiro Iwaki, Hirokazu Takahashi, Miwa Kawanaka, Saiyu Tanaka, Yasuhide Mitsumoto, Masato Yoneda, Atsushi Nakajima, Takeshi Okanoue, Yoshito It |
| Risk factors of hepatocellular carcinoma in non-alcoholic fatty liver disease: a systematic review and meta-analysis. European review for medical and pharmacological sciences 2024 1 27 (24): 11890-11903. W-P Guo, H-Y Zhang, L-X L |
| Prevalence and determinants of liver disease in relatives of Italian patients with advanced MASLD. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024 1 . S Pelusi, L Ronzoni, J Rondena, C Rosso, Pennisi G, P Dongiovanni, S Margarita, R Carpani, G Soardo, D Prati, A Cespiati, S Petta, E Bugianesi, L Valen |
| Genetic predisposition of metabolic dysfunction-associated steatotic liver disease: a population-based genome-wide association study. Hepatology international 2025 1 . Shao-Wen Wang, Ching Wang, Yu-Ming Cheng, Chun-Yi Chen, Tsung-Han Hsieh, Chia-Chi Wang, Jia-Horng K |
- Page last reviewed:Feb 1, 2024
- Content source: